NFKB1 and breast cancer: To determine whether TG2 can activate NF-κB in other cell types, the nuclear extracts from the MCF-7 breast cancer cell line and its drug-resistant sublines thereof (MCF7/RT and MCF-7/DOX) were analyzed for NF-κB activity.